Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance
Jamaal L. James, Brandie C. Taylor, Margaret L. Axelrod, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007736-e007736
Open Access | Times Cited: 11

Showing 11 citing articles:

Exosomal miR-92a-3p modulates M2 macrophage polarization in colorectal cancer: implications for tumor migration and angiogenesis
Wei Zhao, Yudan Wu, Yixiao Wang, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 2
The Application of Dendritic Cells Vaccines in Tumor Therapy and Their Combination with Biomimetic Nanoparticles
Tong Zhu, Yuexin Li, Yutao Wang, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 1
Tumor microenvironment-responsive manganese-based nano-modulator activate the cGAS-STING pathway to enhance innate immune system response
Xiayi Liang, Duo Wang, Yuanquan Zhao, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Loss of tumor cell MHC Class II drives insensitivity of BRAF-mutant anaplastic thyroid cancers to MAPK inhibitors
Vera Tiedje, Jillian Greenberg, Tianyue Qin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer
Lydie M.O. Barbeau, Nicky A. Beelen, Kim G. Savelkouls, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316716-e0316716
Open Access
Dual role of interferon-gamma in the response of melanoma patients to immunotherapy with immune checkpoint inhibitors
Piotr Wawrzyniak, Mariusz L. Hartman
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
A silence catalyst: CCL5-mediated intercellular communication in cancer
Wei‐Ting Hu, Min Li, Peijun Ma, et al.
Archives of Toxicology (2025)
Closed Access
Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy
Jialin Feng, Bo Liang, Wenjie Zheng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 7
Open Access | Times Cited: 2
Transcriptomic analysis of Paraoxonase 1 expression in hepatocellular carcinoma and its potential impact on tumor immunity
Linxiao Dong, Changjun Dong, Yunlin Yu, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 2
CRISPR-inhibition screen for lncRNAs linked to melanoma growth and metastasis
Stavroula Petroulia, Kathryn Hockemeyer, Shashank Tiwari, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
A targetable developmental program co-regulates angiogenesis and immune evasion
Pietro Berico, Amanda Flores Yanke, Fatemeh Van Rajabpour, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Page 1

Scroll to top